KBC Group
MNTA

KBC Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

KBC Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-41,384
Closed -$457K – 1453
2018
Q4 		$457K Sell
41,384
-91,272
-69% -$1.27M 0.01% 945
2018
Q3 		$3.49M Buy
132,656
+11,129
+9% +$301K 0.03% 519
2018
Q2 		$2.48M Hold
121,527
– – 0.02% 558
2018
Q1 		$2.21M Buy
121,527
+19,683
+19% +$328K 0.02% 556
2017
Q4 		$1.42M Buy
101,844
+44,045
+76% +$595K 0.01% 684
2017
Q3 		$1.07M Buy
+57,799
New +$966K 0.01% 793
2016
Q2 		– Sell
-9,250
Closed -$85K – 1330
2016
Q1 		$85K Buy
+9,250
New +$99.5K ﹤0.01% 1166

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

KBC Group's MNTA Position: Q1 2019 in Review

KBC Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2019, closing a stake of 41,384 shares — an estimated $457K sold.

KBC Group first reported a position in MNTA in Q1 2016 and held it in 7 quarters. The position peaked at $3.49M in Q3 2018. 147 funds tracked by Wall St. Rank hold MNTA as of Q1 2019.

  • KBC Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • KBC Group sold 41,384 Momenta Pharmaceuticals, Inc. shares in Q1 2019, an estimated $457K.
  • KBC Group first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2016 and held it in 7 quarters.
  • KBC Group's Momenta Pharmaceuticals, Inc. position peaked at $3.49M in Q3 2018.
  • 147 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2019.

Based on KBC Group's 13F filing for Q1 2019, filed 10 May 2019.